What is prognosis of Breast cancer?

['ⵙⵎⴷ ⵜⴰⵖⴹⴼⵜ ⴰⴷ']

ⵎⴰⵜⵜⴰ ⵜⴰⵏⵏⴰⵢⵜ ⵉⵣⵣⵉⵏ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵡⴰⵔⵔⴰⵎ?

ⴷⴰ ⵉⵜⵜⴰⵡⵢ ⵓⵙⵏⵉⵎⴰⵍ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵡⴰⵔⵔⴰⵙ ⵉ ⵜⵢⴰⴼⵓⵜ ⵉⵜⵜⵓⵙⵏⵎⴰⵍⵏ ⵏⵖⴷ ⵜⴰⵍⵖⴰ ⵏ ⵡⴰⵟⵟⴰⵏ.

ⴷⴰ ⵉⵜⵜⵓⵙⵜⴰⵢ ⵙ ⵓⵎⴰⵜⴰ ⵙ ⵉⵎⵙⴽⴰⵔⵏ ⵣⵓⵏⴷ ⵜⵉⴽⵍⵉ ⵏ ⵍⴽⵓⵏⵚⵉⵕ, ⴰⵏⴰⵡ ⵏ ⵍⴽⵓⵏⵚⵉⵕ, ⴰⵡⵜⴰⵢ ⵏ ⵓⵎⵙⴳⵏⴰⴼ ⴷ ⵜⴷⵓⵙⵉ ⵜⴰⵎⴰⵜⴰⵢⵜ, ⴷ ⵜⵢⴰⴼⵓⵜ ⵏ ⵓⵙⵎⴽⵍ.

ⴽⵓⴷⵏⵏⴰ ⵉⵜⵜⵓⵣⵎⵎⴻⵎ ⵓⴽⵕⴰⵏ ⵏ ⵓⵏⵖⵓⵍ ⴷ ⵉⵜⵜⵓⵊⵊⵉ ⴳ ⵜⵉⵣⵉ ⵉⵣⵡⴰⵔⵏ, ⵜⵍⵍⴰ ⵢⴰⵜ ⵜⵏⴰⴼⵓⵜ ⵉⵖⵓⴷⴰⵏ.

ⴰⵙⵖⵍ ⵏ ⵜⵓⴷⵔⵜ ⵏ ⵙⵎⵎⵓⵙ ⵉⵙⴳⴳⵡⴰⵙⵏ ⵉ ⵡⵉⵏⵏⴰ ⵢⵓⴹⵏⵏ ⵙ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵜⴳⵎⵎⵉ ⵉⴳⴰ 90%, ⵎⴰ ⴰⴷ ⵉⴳⴰⵏ 90% ⵏ ⵡⵉⵏⵏⴰ ⵢⵓⴹⵏⵏ ⵙ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵜⴳⵎⵎⵉ ⴰⵔ ⵙⵓⵍ ⴷⴷⵔⵏ ⵙⵎⵎⵓⵙ ⵉⵙⴳⴳⵡⴰⵙⵏ ⴷⴼⴼⵉⵔ ⵏ ⵜⵓⵙⵙⵏⴰ ⵏⵏⵙⵏ.

ⵎⴰⵛⴰ, ⵉⵇⵇⴰⵏⴷ ⴰⴷ ⵏⵙⵙⴽⵜⵉ ⵎⴰⵙⴷ ⵡⴰⴷⴷⴰⴷ ⵏ ⴽⵓ ⵢⴰⵏ ⵉⴳⴰ ⴰⵎⵢⵉⵡⵏ, ⴷ ⵉⵖⵢ ⴰⴷ ⵉⵎⵣⴰⵔⴰ ⵓⵏⵖⴰⵍ ⵙ ⴽⵉⴳⴰⵏ ⵏ ⵜⵖⴰⵡⵙⵉⵡⵉⵏ ⵉⵥⵍⵉⵏ.

['ⵉⵙⵓⴳⴰⵎ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

McCarthy AM, Manning AK, Hsu S, Welch M, Moy B, Lehman CD, Armstrong K: Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Res Treat. 2022, 196 (2): 389-398.

Han Y, Wang J, Xu B: Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis. Breast. 2020, 54 (): 114-120.

Wang Z, Chen J, Zhong MZ, Huang J, Hu YP, Feng DY, Zhou ZJ, Luo X, Liu ZQ, Jiang WZ, Zhou WB: Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemother Pharmacol. 2017, 79 (3): 535-543.

Zhang L, Han L, Huang Y, Feng Z, Wang X, Li H, Song F, Liu L, Li J, Zheng H, Wang P, Song F, Chen K: SNPs within microRNA binding sites and the prognosis of breast cancer. Aging (Albany NY). 2021, 13 (5): 7465-7480.

Li Y, Duan W, Qi Q, Wang T, Yang Q, Du L, Mao H, Wang C: A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. Cell Death Dis. 2021, 12 (7): 670.

Li N, Li Z, Li X, Chen B, Sun H, Zhao K: Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients. Biomark Med. 2021, 15 (3): 167-180.

['ⴰⵙⴱⴷⵉⴷ: ⴰⵎⵙⵏⵉⵊⵊⵉ']

['ⴰⵙⵉⵜ ⴰⴷ, ⴷⴰ ⵉⵜⵜⵓⴼⴽⴰ ⵖⴰⵙ ⵉ ⵜⵖⴰⵡⵙⵉⵡⵉⵏ ⵏ ⵓⵙⴳⵎⵉ ⴷ ⵉⵏⵖⵎⵉⵙⵏ, ⵓⵔ ⵉⴳⵉ ⴰⵖⴰⵡⴰⵙ ⵏ ⵜⵉⴽⴽⵉ ⵏ ⵜⵉⵏⵓⵔⵣⵉⵜⵉⵏ ⵜⵉⴷⵓⵙⴰⵏⵉⵏ ⵏⵖⴷ ⵜⵉⵡⵓⵔⵉⵡⵉⵏ ⵜⵉⵣⵣⵓⵍⴰⵏⵉⵏ.']

['ⵓⵔ ⵉⵅⵚⵚⴰ ⴰⴷ ⵜⵜⵓⵙⵎⵔⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵎⵔⵙ ⵏ ⵓⵙⵎⵉⴳⵍ ⵏⵉⵖ ⵉⵊⵉⵊⵊⵉ ⵏ ⵉⵎⵓⴽⵔⵉⵙⵏ ⵏ ⵜⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵎⴰⴹⵓⵏⵉⵏ, ⴷ ⵡⵉⵏⵏⴰ ⵉⵔⴰⵏ ⴰⵙⵖⵏⵓ ⴰⵎⵙⵏⵉⵊⵊⵉ ⴰⵡⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⵉⵇⵇⴰⵏ ⴰⴷ ⵉⵙⴰⵡⵍ ⴷ ⵢⴰⵏ ⵓⵎⵙⵏⵉⵊⵊⵉ ⵉⵜⵜⵓⵊⵊⴰⵏ.']

['ⵙⵙⴽⵜⵉ ⴳ ⵜⴱⵔⴰⵜ ⵎⴰⵙ ⵜⵣⵟⵟⴰ ⵏ ⵜⵎⴰⵖⵓⵏⵜ ⵏⵏⴰ ⵉⵜⵜⴰⵔⴰⵏ ⵜⵉⵎⵔⴰⵔⵓⵜⵉⵏ ⵉ ⵉⵙⵇⵙⵉⵜⵏ, ⵓⵔ ⵜⴽⴽⵉ ⵜⵖⴰⵔⴰ ⴽⵉⴳⴰⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵜⵓⵎⴰⵢⵜ ⵏ ⵓⵟⵟⵓⵏ. ⵙ ⵓⵎⴷⵢⴰ, ⵓⵟⵟⵓⵏ ⵏ ⵎⴷⴷⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵉ ⵜⵎⴰⴹⵓⵏⵜ ⵉⵥⵍⵉⵏ.']

['ⴰⵀⴰ ⵣⵣⵔⵉⵢ ⵉ ⵓⵎⵙⴰⵙⴰ ⵏ ⵓⴷⵓⴽⵜⵓⵕ ⵏⵏⴽ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⵙⵙⵉⵡⵍ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏ ⵉⵖⵉⵢⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵓⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵏⵏⴽ. ⵓⵔ ⴰⴽⴽⵡ ⵜⵃⵍⴰⵎ ⴰⵖ ⴰⵖⴰⵎⵓⵙ ⵏ ⵓⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵉⵖⵣⵉ ⴳ ⵓⵙⵣⵣⵔⵉⵢ ⵏⵏⵙ ⴰⵛⴽⵓ ⵏⵜⵜⴰⵜ ⵜⵖⵔⵉⴷ ⴳ ⵓⵙⵉⵜ ⴰⴷ. ⵎⴽ ⵜⵓⵔⴷⴰ ⵎⴰⵙ ⴷⴰⵔⴽ ⴰⴷ ⵢⵉⵍⵉ ⵢⴰⵏ ⵓⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵉⵣⵉⵍⵏ, ⵙⴰⵡⵍⴰⵜ ⵙ 911 ⵏⵖⴷ ⴷⴷⵓ ⵙ ⵓⵙⵉⵔⴰ ⵏ ⵓⵣⵣⵔⴰⵢ ⵏ ⵣⵉⴽⴽ. ⵓⵔ ⴷⴰ ⵉⵜⵜⵓⵙⴽⴰⵔ ⴽⵔⴰ ⵏ ⵓⵣⴷⴰⵢ ⵏ ⵓⵎⵙⴳⵏⴰⴼ ⴷ ⵓⵎⵏⵉⴳ ⵙ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⴰⵙⵎⵔⵙ ⵏⵏⵙ. ⵓⵔ ⴷⴰ ⵜⵙⴽⴰⵔ ⴱⵢⵓⵎⵉⴷⵍⴱ ⵏⵖⴷ ⵉⵎⵙⵡⵓⵔⵉⵏ ⵏⵏⵙ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⴷⵔⴰⵡ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⴽⵔⴰ ⵏ ⵓⵙⵎⵏⵉⴷ, ⵙ ⵡⴰⵡⴰⵍ ⵏⵖⴷ ⵙ ⵓⵙⵓⵎⵔ, ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ.']

['ⵉⵣⵍⵉ: ⵉⵣⵔⴼⴰⵏ ⵏ ⵜⵉⵔⵔⴰ']

['ⵉⵍⵍⴰ ⴳ ⵓⵙⵍⴳⵏ ⵏ ⵓⵣⵔⴼ ⴰⵎⵓⵟⵟⵓⵏ ⵏ ⵓⵙⵏⴼⵍ ⵏ ⵜⵏⵖⵎⴰⵙⵜ ⵏ ⵓⵙⴳⴳⵡⴰⵙ ⵏ 1998, 17 U.S.C. § 512 (DMCA) ⵜⴰⵙⵏⵜⴰⵢⵜ ⵉ ⵉⵎⵥⵢⴰⵏⵏ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵜⵏⵖⵎⴰⵙⵜ ⵏⵏⴰ ⵙⵙⵉⵜⵉⵎⵏ ⵉⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵏⵏⴰ ⴷ ⵉⵜⵜⴼⴼⵖⵏ ⴳ ⵡⴰⵏⵜⵉⵔⵏⵉⵜ ⴷⴰ ⵜⵜⴳⴳⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏⵏⵙⵏ ⴷⴷⴰⵡ ⵓⵣⵔⴼ ⴰⵎⵓⵟⵟⵓⵏ ⴰⵎⵉⵔⵉⴽⴰⵏⵉ. ']

['ⵎⴽ ⵜⵍⵍⵉⴷ ⵙ ⵜⵖⴰⵍⵜ ⵉⵖⵓⴷⴰⵏ ⵎⴰⵙⴷ ⴽⵔⴰ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵙⵏⴼⴰⵔ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⴷⴰⵡ ⵏⵏⵓⵏ ⵏⵖⴷ ⵜⵉⵙⵏⵙⵉ ⵏⵏⵓⵏ ⴷⴰ ⵉⵙⵙⴽⴰⵔ ⵜⵉⵕⵥⵉ ⵏ ⵓⵣⵔⴼ ⵏⵏⵓⵏ ⵏ ⵜⵉⵔⵔⴰ, ⵉⵖⵢ ⴰⴷ ⵜⴰⴷ ⴼⵍⵍⴰⵙ ⵏⵙⵔⵖⴷ (ⵏⵖⴷ ⴰⵎⴷⵢⴰⵣ ⵏⵏⴽ) ⵢⴰⵏ ⵓⵙⵏⵖⵎⵙ ⵏ ⵓⵙⵓⵜⵔ ⵏ ⵓⵙⵏⴼⴰⵔ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⴰⵙⵏⴼⴰⵔ ⴰⴷ ⵏⵖⴷ ⴰⵙⴱⴷⴷⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵓⴽⵛⵛⵓⵎ ⵖⵔⵙⵏ. ']

['ⵉⵇⵇⴰⵏ ⴰⴷ ⵜⵜⵢⵓⵔⴰⵢ ⵜⴱⵔⴰⵜ ⴰⴷ ⵙ ⵜⵖⴰⵔⴰⵙⵜ ⵏ ⵜⵉⵔⵔⴰ ⵙ ⵜⴱⵔⴰⵜ ⵜⵉⵍⵉⴽⵜⵕⵓⵏⵉⵜ (ⵥⵕ ⴰⵙⴷⴰⵡ ⵏ ⵜⴱⵔⴰⵜ ⵜⵉⵍⵉⴽⵜⵕⵓⵏⵉⵜ ⴳ ⵓⵎⵏⵏⵉ "ⵉⵎⵢⴰⵡⴰⴹⵏ").']

['ⴷⴰ ⵉⵜⵜⴻⵖⵜⴰⵙ ⵓⵙⵍⴳⵏ ⵏ ⵓⵎⵏⵖⵉ ⵅⴼ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵉⵙ ⴷ ⵉⵇⵇⴰⵏ ⴰⴷ ⴳⵉⵙ ⵉⵍⵉⵏ ⵉⵏⵖⵎⵉⵙⵏ ⴰⴷ: (1) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵡⵓⵔⵉ ⵉⵍⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵜⵍ ⵏ ⵓⵣⵔⴼ ⵏ ⵓⵎⴳⴰⵢ; (2) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵓⵎⵍ ⵏ ⵉⵣⵔⴼⴰⵏ ⴷ ⵉⵏⵖⵎⵉⵙⵏ ⵏⵏⴰ ⵢⵓⵙⴰⵏ ⵃⵎⴰ ⴰⴷ ⵜ ⵏⴰⴼ; (3) ⵉⵏⵖⵎⵉⵙⵏ ⵏ ⵓⵎⵢⴰⵡⴰⴹ ⴰⴽⴷⴽ, ⴳ ⵉⵍⵍⴰ ⵓⵙⵖⵉⵎ ⵏⵏⴽ ⴷ ⵓⵟⵟⵓⵏ ⵏ ⵜⵉⵍⵉⴼⵓⵏ ⴷ ⵓⴷⵖⴰⵔ ⵏ ⵍⵢⵉⴱⵍ; (4) ⴰⵙⵉⵡⴹ ⵏⵏⴽ ⵏ ⵓⵙⵏⵓⵎⵍ ⵉⵖⵓⴷⴰⵏ ⵏⵏⴰ ⴳ ⵜⵍⵍⴰ ⵜⵣⵎⵎⴰⵔ ⵏ ⵓⵙⵏⵓⵎⵍ ⵏ ⵓⵙⵏⴼⵍ ⵏⵏⴰ ⵙ ⵉⵜⵜⵓⵙⵎⴳⴰⵍ ⵓⵔ ⵜ ⵢⵓⵊⵊⵉ ⵓⵎⵏⴳⴰⵢ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ, ⵏⵖⴷ ⵓⵎⴷⵢⴰⵣ ⵏⵏⵙ, ⵏⵖⴷ ⵙ ⵓⴹⴼⴰⵕ ⵏ ⴽⵔⴰ ⵏ ⵓⵙⵍⴳⵏ; ']

['5. ⵢⴰⵏ ⵓⵙⵉⵡⴹ ⵏⵏⴽ, ⵉⵜⵜⵓⵙⴳⵎⴰⴹⵏ ⴷⴷⵓ ⵏ ⵓⵃⵟⵟⵓ ⵏ ⵜⵔⴳⴰⵍⵜ, ⵎⴰⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵍⵍⴰⵏ ⴳ ⵓⵏⵖⵎⵉⵙ ⴰⴷ ⴳⴰⵏ ⵉⵙⴷⴰⵡⵏ ⴷ ⵎⴰⵙ ⵖⵓⵔⴽ ⵜⵓⵔⴰⴳⵜ ⴰⴼⴰⴷ ⴰⴷ ⵜⵙⵎⴷⵔⴼ ⵜⵉⵡⵏⴳⵉⵎⵉⵏ ⵉⵜⵜⵉⵏⵉ ⵉⵙ ⵜⵜⵓⵙⵏⴼⴰⵍⵏ;']

['ⴷ (6) ⵢⴰⵏ ⵓⵣⵎⵎⴻⵎ ⴰⴽⵎⴰⵎ ⵏⵖⴷ ⴰⵍⵉⴽⵜⵔⵓⵏⵉ ⵏ ⵉⵎⵥⵍⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵜⵉⵔⵔⴰ ⵏⵖⴷ ⵢⴰⵏ ⵓⴼⴳⴰⵏ ⵉⵜⵜⵓⵙⵎⴰⴳⵍⵏ ⵙ ⵜⵡⵓⵔⵉ ⴳ ⵜⵙⴳⴰ ⵏ ⵉⵎⵥⵍⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵜⵉⵔⵔⴰ. ']

['ⵎⴽ ⵓⵔ ⵜⵙⵎⵓⵜⵜⵉⴷ ⴽⵓⵍⵍⵓ ⵉⵏⵖⵎⵉⵙⵏ ⴰⴼⵍⵍⴰ, ⵉⵥⴹⴰⵕ ⴰⴷ ⵉⵙⵙⵉⵍⵉ ⵓⵙⵙⵉⵖⵣⵉⵏ ⵏ ⵓⵙⵎⴽⵍ ⵏ ⵡⴰⵙⵉⴼ ⵏⵏⴽ.']

['ⴰⵎⵢⴰⵡⴰⴹ']

['ⵙⵇⵙⴰⵖ ⴷⵉⵖ ⴰⴷ ⵜⵙⵏⵖⵎⵙⴷ ⴽⵔⴰ ⵏ ⵓⵙⵇⵙⵉ/ ⵜⴰⵏⵏⴰⵢⵜ.']

What is prognosis of breast cancer?

The prognosis of breast cancer refers to the predicted outcome or likely course of the disease.

It is typically determined by factors such as the stage of the cancer, the type of cancer, the patient's age and overall health, and the effectiveness of treatment.

The earlier breast cancer is detected and treated, the better the prognosis tends to be.

The five-year survival rate for breast cancer patients is around 90%, meaning that 90% of patients diagnosed with breast cancer are still alive five years after their diagnosis.

However, it is important to note that every individual's situation is unique, and the prognosis can vary greatly depending on the specific circumstances.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['ⵖⴼ']

['ⴷⴰ ⵉⵙⵙⵎⵔⴰⵙ ⴱⵢⵓⵎⵉⴷⵍⴱ ⵉⵎⴰⵙⵙⵏ ⵏ ⵓⵙⵖⵉⵡⵙ ⵉⵙⵎⵎⴰⵏⵏ (ⴰⵍⴳⵓⵔⵉⵜⵎ ⵏ ⵓⵍⵎⵎⵓⴷ ⵏ ⵉⵎⵉⵙⵏ) ⵉ ⵓⵙⵓⴼⵖ ⵏ ⵉⴽⵔⵡⴰⵏ ⵏ ⵉⵙⵇⵙⵉⵜⵏ ⴷ ⵜⵎⵔⴰⵔⵓⵜⵉⵏ.']

['ⴷⴰ ⵏⵙⵙⵏⵜⵉ ⵙ 35 ⵎⵍⵢⵓⵏ ⵏ ⵜⵥⵕⵉⴳⵉⵏ ⵜⵉⵎⵙⵏⵉⵊⵊⵉⵏ ⵏ ⵜⵓⴷⵔⵜ ⵏ ⴱⵓⴱⵎⵉⴷ/ⵎⵉⴷⵍⵉⵏ. ⴰⵡⴷ ⵜⵉⴼⵔⵜ ⵏ ⵡⵉⴱ ⵏ ⵔⵉⴼⵉⵏⴷⵡⵉⴱ.']

['ⵥⵕ "ⵜⵓⵎⴰⵔ" ⴰⵡⴷ "ⴰⵙⵎⵉⴳⵍ".']